Nishioka, Yuichi
Morita, Emiri
Takeshita, Saki
Tamamoto, Sakura
Myojin, Tomoya
Noda, Tatsuya
Imamura, Tomoaki
Article History
Received: 22 December 2022
Accepted: 11 January 2024
First Online: 2 February 2024
Declarations
:
: YN received consultation fees from Novo Nordisk. The other authors declare that they have no conflicts of interest.
: All methods were conducted in accordance with relevant guidelines and regulations. All experimental protocols were approved by the Ethics Committee of Nara Medical University (approval no. 1123–7, October 8th, 2015). The need for informed consent was waived in view of the study design; all patient data were anonymized before analysis.
: Not applicable.